Herein, panobinostat can not only attenuate CCI-induced nociceptive sensitization but also downregulate HDAC activity, which leads to restore GAD65 expression, inhibited by HDAC, in the SCDH under neuropathy. Here, GAD2 is linked to neuropathy.